Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01525810
What this trial is testing

Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 218
Large-scale testing (Phase 3)Ended earlyNCT00122629
What this trial is testing

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Who this might be right for
Hepatitis C, Chronic
French National Agency for Research on AIDS and Viral Hepatitis 405
Large-scale testing (Phase 3)Study completedNCT01945294
What this trial is testing

Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 257
Large-scale testing (Phase 3)Study completedNCT02517528
What this trial is testing

ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C Virus (HCV)
AbbVie 104
Not applicableStudy completedNCT01857245
What this trial is testing

Intensive Models of HCV Care for Injection Drug Users

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 150
Testing effectiveness (Phase 2)Study completedNCT02175966
What this trial is testing

Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 35
Not applicableStudy completedNCT02807402
What this trial is testing

Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania

Who this might be right for
Chronic Hepatitis C
AbbVie 522
Early research (Phase 1)Study completedNCT01813513
What this trial is testing

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 42
Not applicableStudy completedNCT02176980
What this trial is testing

Hepatitis C Alcohol Reduction Treatment

Who this might be right for
Hepatitis C, Chronic; AUD
Duke University 182
Not applicableStudy completedNCT03453346
What this trial is testing

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus Infection, Response to Therapy of
Kawin Technology Share-holding Co., Ltd. 136
Large-scale testing (Phase 3)Study completedNCT01425203
What this trial is testing

The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)

Who this might be right for
Chronic Hepatitis C Genotype 1
Merck Sharp & Dohme LLC 238
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Not applicableStudy completedNCT01544582
What this trial is testing

Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)

Who this might be right for
Hepatitis C Chronic
Merck Sharp & Dohme LLC 713
Testing effectiveness (Phase 2)Study completedNCT02493855
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 46
Not applicableStudy completedNCT00704717
What this trial is testing

Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 185
Not applicableUnknownNCT03687229
What this trial is testing

The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients

Who this might be right for
Chronic Hepatitis c
Assiut University 60
Early research (Phase 1)Study completedNCT01678131
What this trial is testing

Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 31
Large-scale testing (Phase 3)Study completedNCT02966795
What this trial is testing

Of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 84
Large-scale testing (Phase 3)Study completedNCT01995266
What this trial is testing

Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 218
Testing effectiveness (Phase 2)Study completedNCT01782495
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 129
Next Page